Skip to main content
Log in

Abnormal Changes of IL3/IL3R and Its Downstream Signaling Pathways in the Prion-Infected Cell Line and in the Brains of Scrapie-Infected Rodents

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Interleukin 3 (IL-3) plays an important role in hematopoiesis and immune regulation, brain IL-3/IL-3R signaling has been shown to involve in the physiological and pathological processes of a variety of neurodegenerative diseases, but its role in prion diseases is rarely described. Here, the changes of IL-3/IL-3R and its downstream signaling pathways in a scrapie-infected cell line and in the brains of several scrapie-infected rodent models were evaluated by various methods. Markedly decreased IL-3Rα were observed in the brains of scrapie-infected rodents at terminal stage and in the prion-infected cell model, which showed increased in the brain samples collected at early and middle stage of infection. The IL-3 levels were almost unchanged in the brains of scrapie-infected mice and in the prion-infected cell line. Morphological assays identified close co-localization of the increased IL-3Rα signals with NeuN- and Iba1-positive cells, whereas co-localization of IL-3 signals with NeuN- and GFAP-positive cells in the scrapie-infected brain tissues. Some downstream components of IL-3/IL-3R pathways, including JAK2-STAT5 and PI3K/AKT/mTOR pathways, were downregulated in the brains of scrapie-infected rodents at terminal stage and in the prion-infected cells. Stimulation of recombinant IL-3 on the cultured cells showed prion that the prion-infected cells displayed markedly more reluctant responses of JAK2-STAT5 and PI3K/AKT/mTOR pathways than the normal partner cells. These data suggest that although prion infection or PrPSc accumulation in brain tissues does not affect IL-3 expression, it significantly downregulates IL-3R levels, thereby inhibiting the downstream pathways of IL-3/IL-3R and blocking the neuroregulatory and neuroprotective activities of IL-3.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

Data Availability

The datasets generated for this study are available on request to the corresponding.

References

  1. Baldwin KJ, Correll CM (2019) Prion disease. Semin Neurol 39(4):428–439. https://doi.org/10.1055/s-0039-1687841

    Article  PubMed  Google Scholar 

  2. Prusiner SB (1998) Prions. Proc Natl Acad Sci U S A 95(23):13363–13383. https://doi.org/10.1073/pnas.95.23.13363

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Wadsworth JD, Collinge J (2011) Molecular pathology of human prion disease. Acta Neuropathol 121(1):69–77. https://doi.org/10.1007/s00401-010-0735-5

    Article  CAS  PubMed  Google Scholar 

  4. Aguzzi A, Zhu C (2017) Microglia in prion diseases. J Clin Invest 127(9):3230–3239. https://doi.org/10.1172/JCI90605

    Article  PubMed  PubMed Central  Google Scholar 

  5. Mindur JE, Swirski FK (2019) Growth factors as immunotherapeutic targets in cardiovascular disease. Arterioscler Thromb Vasc Biol 39(7):1275–1287. https://doi.org/10.1161/ATVBAHA.119.311994

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Appel K, Buttini M, Sauter A, Gebicke-Haerter PJ (1995) Cloning of rat interleukin-3 receptor beta-subunit from cultured microglia and its mRNA expression in vivo. J Neurosci 15(8):5800–5809. https://doi.org/10.1523/JNEUROSCI.15-08-05800.1995

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Natarajan C, Sriram S, Muthian G, Bright JJ (2004) Signaling through JAK2-STAT5 pathway is essential for IL-3-induced activation of microglia. Glia 45(2):188–196. https://doi.org/10.1002/glia.10316

    Article  PubMed  Google Scholar 

  8. Kiddle SJ, Thambisetty M, Simmons A, Riddoch-Contreras J, Hye A, Westman E, Pike I, Ward M et al (2012) Plasma based markers of [11C] PiB-PET brain amyloid burden. PLoS ONE 7(9):e44260. https://doi.org/10.1371/journal.pone.0044260

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Zambrano A, Otth C, Maccioni RB, Concha II (2010) IL-3 controls tau modifications and protects cortical neurons from neurodegeneration. Curr Alzheimer Res 7(7):615–624. https://doi.org/10.2174/156720510793499011

    Article  CAS  PubMed  Google Scholar 

  10. Frendl G, Beller DI (1990) Regulation of macrophage activation by IL-3. I. IL-3 functions as a macrophage-activating factor with unique properties, inducing Ia and lymphocyte function-associated antigen-1 but not cytotoxicity. J Immunol 144(9):3392–3399

    Article  CAS  PubMed  Google Scholar 

  11. Frendl G (1992) Interleukin 3: from colony-stimulating factor to pluripotent immunoregulatory cytokine. Int J Immunopharmacol 14(3):421–430. https://doi.org/10.1016/0192-0561(92)90172-h

    Article  CAS  PubMed  Google Scholar 

  12. Frei K, Bodmer S, Schwerdel C, Fontana A (1986) Astrocyte-derived interleukin 3 as a growth factor for microglia cells and peritoneal macrophages. J Immunol 137(11):3521–3527

    Article  CAS  PubMed  Google Scholar 

  13. McAlpine CS, Park J, Griciuc A, Kim E, Choi SH, Iwamoto Y, Kiss MG, Christie KA et al (2021) Astrocytic interleukin-3 programs microglia and limits Alzheimer’s disease. Nature 595(7869):701–706. https://doi.org/10.1038/s41586-021-03734-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Clarke MC, Haig DA (1971) Multiplication of scrapie agent in mouse spleen. Res Vet Sci 12(2):195–197

    Article  CAS  PubMed  Google Scholar 

  15. Birkett CR, Hennion RM, Bembridge DA, Clarke MC, Chree A, Bruce ME, Bostock CJ (2001) Scrapie strains maintain biological phenotypes on propagation in a cell line in culture. EMBO J 20(13):3351–3358. https://doi.org/10.1093/emboj/20.13.3351

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Shi Q, Zhang BY, Gao C, Zhang J, Jiang HY, Chen C, Han J, Dong XP (2012) Mouse-adapted scrapie strains 139A and ME7 overcome species barrier to induce experimental scrapie in hamsters and changed their pathogenic features. Virol J 9:63. https://doi.org/10.1186/1743-422X-9-63

    Article  PubMed  PubMed Central  Google Scholar 

  17. Hu C, Chen C, Xia Y, Chen J, Yang W, Wang L, Chen D-D, Wu Y-Z et al (2022) Different Aberrant changes of mglur5 and its downstream signaling pathways in the scrapie-infected cell line and the brains of scrapie-infected experimental rodents. Front Cell Dev Biol 10. https://doi.org/10.3389/fcell.2022.844378

  18. Huang SCZ, Yu JF, Young D, Bashey A, Ho AD, Law P (1999) Correlation between IL-3 receptor expression and growth potential of human CD34+ hematopoietic cells from different tissues. Stem Cells 17(5):265–272. https://doi.org/10.1002/stem.170265

    Article  CAS  PubMed  Google Scholar 

  19. Fogha J, Bayry J, Diharce J, de Brevern AG (2021) Structural and evolutionary exploration of the IL-3 family and its alpha subunit receptors. Amino Acids 53(8):1211–1227. https://doi.org/10.1007/s00726-021-03026-3

    Article  CAS  PubMed  Google Scholar 

  20. Zambrano A, Otth C, Mujica L, Concha II, Maccioni RB (2007) Interleukin-3 prevents neuronal death induced by amyloid peptide. BMC Neurosci 8:82. https://doi.org/10.1186/1471-2202-8-82

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Wen TC, Tanaka J, Peng H, Desaki J, Matsuda S, Maeda N, Fujita H, Sato K et al (1998) Interleukin 3 prevents delayed neuronal death in the hippocampal CA1 field. J Exp Med 188(4):635–649. https://doi.org/10.1084/jem.188.4.635

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Frei K, Bodmer S, Schwerdel C, Fontana A (1985) Astrocytes of the brain synthesize interleukin 3-like factors. J Immunol 135(6):4044–4047

    Article  CAS  PubMed  Google Scholar 

  23. Konishi Y, Kamegai M, Takahashi K, Kunishita T, Tabira T (1994) Production of interleukin-3 by murine central nervous system neurons. Neurosci Lett 182(2):271–274. https://doi.org/10.1016/0304-3940(94)90814-1

    Article  CAS  PubMed  Google Scholar 

  24. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR et al (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275(5300):661–665. https://doi.org/10.1126/science.275.5300.661

    Article  CAS  PubMed  Google Scholar 

  25. Chen C, Shi Q, Xiao K, Zhou W, Gao C, Gao L, Han J, Wang J et al (2022) Activation of innate immunity and autophagy in brain tissues with prion disease and degradation of abnormal PrPs in Cells - China’s Studies. China CDC Wkly 4(33):735–740. https://doi.org/10.46234/ccdcw2022.153

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Shi Q, Chen C, Xiao K, Zhou W, Gao C, Gao L, Han J, Wang J et al (2022) Extensive disturbances of intracellular components and dysfunctions of biological pathways in the brain tissues during prion infection - China’s Studies. China CDC Wkly 4(33):741–747. https://doi.org/10.46234/ccdcw2022.154

    Article  PubMed  PubMed Central  Google Scholar 

  27. Chen J, Chen C, Hu C, Liu L, Xia Y, Wang L, Yang W, Wu HY et al (2020) IP10, KC and M-CSF are remarkably increased in the brains from the various strains of experimental mice infected with different scrapie agents. Virol Sin 35(5):614–625. https://doi.org/10.1007/s12250-020-00216-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Xia Y, Chen C, Chen J, Hu C, Yang W, Wang L, Liu L, Gao L-P et al (2022) Enhanced M-CSF/CSF1R signaling closely associates with PrPSc Accumulation in the scrapie-infected cell line and the brains of scrapie-infected experimental rodents. Mol Neurobiol 59(10):6534–6551. https://doi.org/10.1007/s12035-022-02989-y

    Article  CAS  PubMed  Google Scholar 

  29. Abedpoor N, Taghian F, Hajibabaie F (2022) Cross brain-gut analysis highlighted hub genes and LncRNA networks differentially modified during leucine consumption and endurance exercise in mice with depression-like behaviors. Mol Neurobiol 59(7):4106–4123. https://doi.org/10.1007/s12035-022-02835-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work was supported by SKLID Development Grant (2021SKLID504, 2019SKLID401, 2019SKLID603).

Author information

Authors and Affiliations

Authors

Contributions

XXJ and CC contributed to study design, performed assays and data analysis, and prepared the manuscript. CH, ZYC, and WWZ assisted with the assays of cultured cells. WYZ, QF, RHA, and XL assisted with WB and IFA analysis assays. KX and QS assisted with statistical analysis. CC and XPD contributed to design, study concept, and manuscript preparation.

Corresponding authors

Correspondence to Cao Chen or Xiao-Ping Dong.

Ethics declarations

Ethics Approval

Not applicable.

Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PNG 2223 kb)

High resolution image (TIF 2787 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jia, XX., Chen, C., Hu, C. et al. Abnormal Changes of IL3/IL3R and Its Downstream Signaling Pathways in the Prion-Infected Cell Line and in the Brains of Scrapie-Infected Rodents. Mol Neurobiol (2023). https://doi.org/10.1007/s12035-023-03511-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12035-023-03511-8

Keywords

Navigation